Anesthetic neurotoxicity--clinical implications of animal models.
Bob A Rappaport, Santhanam Suresh, Sharon Hertz...
https://pubmed.ncbi.nlm.nih.gov/25714157/Actively Recruiting
Led by Boston Children's Hospital · Updated on 2026-09-21
105
Participants Needed
1
Research Sites
13 weeks
Total Duration
Researchers are investigating sedation methods for children aged 1 to 12 years undergoing magnetic resonance imaging MRI. The study compares traditional propofol-only sedation to combinations of dexmedetomidine and propofol to find the optimal dose that provides effective sedation while minimizing exposure to anesthetic drugs. This trial is motivated by concerns about possible neurotoxic effects of common anesthetics and aims to explore alternatives that might reduce risks and improve recovery. Participants are randomly assigned to one of three groups propofol-only, high-dose dexmedetomidine with propofol, or low-dose dexmedetomidine with propofol. Each group receives specific dosing regimens involving intravenous boluses of dexmedetomidine andor propofol followed by propofol infusions adjusted to maintain a sedation score between 5 and 6. The study records sedative dosing, recovery times, and any technical sedation failures during MRI scans lasting between 30 and 90 minutes. During the trial, children receive sedation under careful monitoring with measures including sedation scores, emergence delirium scales, and recording of adverse events or interruptions during the MRI. Recovery times and propofol consumption are closely tracked up to several hours after sedation. The study aims to determine the best sedation approach balancing effective sedation, quick recovery, and safety, with participant involvement lasting through the MRI and post-anesthesia care unit stay.
CONDITIONS
Propofol-Only Versus Dexmedetomidine-Propofol in Children Undergoing Magnetic Resonance Imaging
S
Samuel Kim, BS
R
Rachel Bernier, MPH
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Boston Children's Hospital
Lead Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | Propofol Alone | Low-Dose Dexmedetomidine + Propofol | High-Dose Dexmedetomidine + Propofol |
|---|---|---|---|
| What it is | A sedation regimen using IV propofol alone for induction and maintenance during MRI in children. | A combination of low-dose IV dexmedetomidine (0.5 mcg/kg bolus) with a propofol bolus (1-2 mg/kg) and lower-rate infusion for MRI sedation. | A regimen using a higher IV dexmedetomidine bolus (1 mcg/kg) plus propofol bolus and lower-rate propofol infusion for pediatric MRI sedation. |
| Role in this trial | Serves as the comparator arm to evaluate how adding dexmedetomidine affects sedation in children undergoing MRI. | Tests whether adding a low dose of dexmedetomidine to propofol improves sedation quality, reduces propofol needs, or changes recovery outcomes. | Assesses the impact of a higher dexmedetomidine dose added to propofol, focusing on its effect on sedation requirements and emergence phenomena. |
| Primary use | Intended to provide deep sedation for pain-free, motionless MRI in children. | Designed to deliver deep sedation with potential for smoother recovery or reduced emergence events during MRI in children. | Aims to achieve effective sedation and minimize post-procedure emergence agitation by using high-dose dexmedetomidine with propofol. |
| How it is given or performed | IV bolus of propofol (2-4 mg/kg) followed by continuous infusion (250 mcg/kg/min) until scan is completed. | IV dexmedetomidine 0.5 mcg/kg over 5 minutes, then propofol bolus (1-2 mg/kg) and continuous infusion (150 mcg/kg/min). | IV dexmedetomidine 1 mcg/kg over 5 minutes, followed by propofol bolus (1-2 mg/kg) and maintenance infusion (150 mcg/kg/min). |
| Evidence status | Propofol alone is supported by large observational studies as effective in providing deep sedation for MRI, but is associated with a higher risk of emergence delirium in some patients. | Adding low-dose dexmedetomidine to propofol may reduce total propofol requirement and show trends toward lower emergence delirium, but published studies suggest effects are modest and technique may prolong recovery time. | High-dose dexmedetomidine with propofol can further reduce emergence agitation, with the potential for greater reduction compared to low-dose, but may be associated with even longer awakening and recovery times. |
| Important limitations | Propofol alone may lead to higher rates of emergence delirium or agitation post-procedure and can require higher anesthetic doses to maintain sedation, increasing risk of hypotension or respiratory depression. | Use of low-dose dexmedetomidine with propofol is associated with longer recovery time in post-anesthesia care, potential for delayed awakening, and may not eliminate emergence agitation completely. | High-dose dexmedetomidine further extends awakening and recovery time, increasing procedure duration and delaying discharge; dosing must be balanced against the clinical need for rapid recovery. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 90 minutes or duration of MRI scan
Participants receive sedation with either propofol alone or dexmedetomidine combined with propofol during their MRI scan. Sedative doses are adjusted to maintain adequate sedation.
1 visit (in-person)
Duration - Up to 180 minutes or duration of PACU stay
Participants are monitored in the post-anesthesia care unit to assess recovery, emergence delirium, and any adverse events following sedation.
1 follow-up visit (in-person)
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
3
Have more questions? Get in touch with our team for quick support
Bob A Rappaport, Santhanam Suresh, Sharon Hertz...
https://pubmed.ncbi.nlm.nih.gov/25714157/Michael D Mallory, Curtis Travers, Joseph P Cravero...
https://pubmed.ncbi.nlm.nih.gov/36173243/Samuel Y Kim, Jocelyn M Booth, Steven J Staffa...
https://pubmed.ncbi.nlm.nih.gov/40349256/Makoto Nagoshi, Swayta Reddy, Marisa Bell...
https://pubmed.ncbi.nlm.nih.gov/29882298/Shwethashri Kondavagilu Ramaprasannakumar, Varadarajan Bhadrinarayan, Sudhir Venkataramaiah
https://pubmed.ncbi.nlm.nih.gov/36620110/Amy E Vinson, James Peyton, Anna Kordun...
https://pubmed.ncbi.nlm.nih.gov/34036674/Juan P Boriosi, Jens C Eickhoff, Kristi B Klein...
https://pubmed.ncbi.nlm.nih.gov/27779360/Boston Children's Hospital
Lead Sponsor